Proximity Ligation Assay Reveals Co-Localization of Alpha-Synuclein and SNARE Proteins in Murine Primary Neurons

Overview

Journal Front Neurol

Specialty Neurology

Date 2018 Apr 7

PMID 29623065

Citations 17

Authors

Leire Almandoz-Gil

Emma Persson

Veronica Lindstrom

Martin Ingelsson

Anna Erlandsson

Joakim Bergstrom

Affiliations

Soon will be listed here.

Abstract

The aggregation of alpha-synuclein (αSyn) is the pathological hallmark of Parkinson's disease, dementia with Lewy bodies and related neurological disorders. However, the physiological function of the protein and how this function relates to its pathological effects remain poorly understood. One of the proposed roles of αSyn is to promote the soluble -ethylmaleimide-sensitive factor attachment protein receptor (SNARE) complex assembly by binding to VAMP-2. The objective of this study was to visualize the co-localization between αSyn and the SNARE proteins (VAMP-2, SNAP-25, and syntaxin-1) for the first time using proximity ligation assay (PLA). Cortical primary neurons were cultured from either non-transgenic or transgenic mice expressing human αSyn with the A30P mutation under the Thy-1 promoter. With an antibody recognizing both mouse and human αSyn, a PLA signal indicating close proximity between αSyn and the three SNARE proteins was observed both in the soma and throughout the processes. No differences in the extent of PLA signals were seen between non-transgenic and transgenic neurons. With an antibody specific against human αSyn, the PLA signal was mostly located to the soma and was only present in a few cells. Taken together, PLA is a method that can be used to investigate the co-localization of αSyn and the SNARE proteins in primary neuronal cultures.

Citing Articles

Exploring α-synuclein Interaction Partners and their Potential Clinical Implications for Parkinson's Disease.

Chen Y, Gu Y, Cao C, Zheng Q, Sun L, Ding W Neurochem Res. 2024; 50(1):23.

PMID: 39560845 DOI: 10.1007/s11064-024-04250-5.

Serine-129 phosphorylation of α-synuclein is an activity-dependent trigger for physiologic protein-protein interactions and synaptic function.

Parra-Rivas L, Madhivanan K, Aulston B, Wang L, Prakashchand D, Boyer N Neuron. 2023; 111(24):4006-4023.e10.

PMID: 38128479 PMC: 10766085. DOI: 10.1016/j.neuron.2023.11.020.

Altered Distribution of SNARE Proteins in Primary Neurons Exposed to Different Alpha-Synuclein Proteoforms.

Brolin E, Ingelsson M, Bergstrom J, Erlandsson A Cell Mol Neurobiol. 2023; 43(6):3023-3035.

PMID: 37130995 PMC: 10333399. DOI: 10.1007/s10571-023-01355-3.

Monitoring α-synuclein aggregation.

Estaun-Panzano J, Arotcarena M, Bezard E Neurobiol Dis. 2022; 176:105966.

PMID: 36527982 PMC: 9875312. DOI: 10.1016/j.nbd.2022.105966.

Jesko H, Wieczorek I, Wencel P, Gassowska-Dobrowolska M, Lukiw W, Strosznajder R Front Mol Neurosci. 2021; 14:660104.

PMID: 34305524 PMC: 8299068. DOI: 10.3389/fnmol.2021.660104.

References

Soderberg O, Gullberg M, Jarvius M, Ridderstrale K, Leuchowius K, Jarvius J . Direct observation of individual endogenous protein complexes in situ by proximity ligation. Nat Methods. 2006; 3(12):995-1000. DOI: 10.1038/nmeth947. View

Yu S, Li X, Liu G, Han J, Zhang C, Li Y . Extensive nuclear localization of alpha-synuclein in normal rat brain neurons revealed by a novel monoclonal antibody. Neuroscience. 2007; 145(2):539-55. DOI: 10.1016/j.neuroscience.2006.12.028. View

Lindstrom V, Fagerqvist T, Nordstrom E, Eriksson F, Lord A, Tucker S . Immunotherapy targeting α-synuclein protofibrils reduced pathology in (Thy-1)-h[A30P] α-synuclein mice. Neurobiol Dis. 2014; 69:134-43. DOI: 10.1016/j.nbd.2014.05.009. View

Burre J, Sharma M, Tsetsenis T, Buchman V, Etherton M, Sudhof T . Alpha-synuclein promotes SNARE-complex assembly in vivo and in vitro. Science. 2010; 329(5999):1663-7. PMC: 3235365. DOI: 10.1126/science.1195227. View

Sollner T, Whiteheart S, Brunner M, Erdjument-Bromage H, Geromanos S, Tempst P . SNAP receptors implicated in vesicle targeting and fusion. Nature. 1993; 362(6418):318-24. DOI: 10.1038/362318a0. View

Schell H, Hasegawa T, Neumann M, Kahle P . Nuclear and neuritic distribution of serine-129 phosphorylated alpha-synuclein in transgenic mice. Neuroscience. 2009; 160(4):796-804. DOI: 10.1016/j.neuroscience.2009.03.002. View

Kahle P, Neumann M, Ozmen L, Muller V, Jacobsen H, Schindzielorz A . Subcellular localization of wild-type and Parkinson's disease-associated mutant alpha -synuclein in human and transgenic mouse brain. J Neurosci. 2000; 20(17):6365-73. PMC: 6772969. View

Roberts R, Wade-Martins R, Alegre-Abarrategui J . Direct visualization of alpha-synuclein oligomers reveals previously undetected pathology in Parkinson's disease brain. Brain. 2015; 138(Pt 6):1642-57. PMC: 4614141. DOI: 10.1093/brain/awv040. View

Fagerqvist T, Lindstrom V, Nordstrom E, Lord A, Tucker S, Su X . Monoclonal antibodies selective for α-synuclein oligomers/protofibrils recognize brain pathology in Lewy body disorders and α-synuclein transgenic mice with the disease-causing A30P mutation. J Neurochem. 2013; 126(1):131-44. DOI: 10.1111/jnc.12175. View

10.

Ekmark-Lewen S, Lindstrom V, Gumucio A, Ihse E, Behere A, Kahle P . Early fine motor impairment and behavioral dysfunction in (Thy-1)-h[A30P] alpha-synuclein mice. Brain Behav. 2018; 8(3):e00915. PMC: 5840441. DOI: 10.1002/brb3.915. View

11.

Maroteaux L, Campanelli J, Scheller R . Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal. J Neurosci. 1988; 8(8):2804-15. PMC: 6569395. View

12.

Kruger R, Kuhn W, Muller T, Woitalla D, Graeber M, Kosel S . Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. Nat Genet. 1998; 18(2):106-8. DOI: 10.1038/ng0298-106. View

13.

Kollias G, Spanopoulou E, Grosveld F, Ritter M, Beech J, Morris R . Differential regulation of a Thy-1 gene in transgenic mice. Proc Natl Acad Sci U S A. 1987; 84(6):1492-6. PMC: 304460. DOI: 10.1073/pnas.84.6.1492. View

14.

Soderberg O, Leuchowius K, Gullberg M, Jarvius M, Weibrecht I, Larsson L . Characterizing proteins and their interactions in cells and tissues using the in situ proximity ligation assay. Methods. 2008; 45(3):227-32. DOI: 10.1016/j.ymeth.2008.06.014. View

15.

Bussell Jr R, Eliezer D . Effects of Parkinson's disease-linked mutations on the structure of lipid-associated alpha-synuclein. Biochemistry. 2004; 43(16):4810-8. DOI: 10.1021/bi036135+. View

16.

Gomez-Tortosa E, Newell K, Irizarry M, Albert M, Growdon J, Hyman B . Clinical and quantitative pathologic correlates of dementia with Lewy bodies. Neurology. 1999; 53(6):1284-91. DOI: 10.1212/wnl.53.6.1284. View

17.

Bellucci A, Navarria L, Falarti E, Zaltieri M, Bono F, Collo G . Redistribution of DAT/α-synuclein complexes visualized by "in situ" proximity ligation assay in transgenic mice modelling early Parkinson's disease. PLoS One. 2011; 6(12):e27959. PMC: 3233557. DOI: 10.1371/journal.pone.0027959. View

18.

Kramer M, Schulz-Schaeffer W . Presynaptic alpha-synuclein aggregates, not Lewy bodies, cause neurodegeneration in dementia with Lewy bodies. J Neurosci. 2007; 27(6):1405-10. PMC: 6673583. DOI: 10.1523/JNEUROSCI.4564-06.2007. View

19.

Burre J, Vivona S, Diao J, Sharma M, Brunger A, Sudhof T . Properties of native brain α-synuclein. Nature. 2013; 498(7453):E4-6. PMC: 4255827. DOI: 10.1038/nature12125. View

20.

Burre J, Sharma M, Sudhof T . Systematic mutagenesis of α-synuclein reveals distinct sequence requirements for physiological and pathological activities. J Neurosci. 2012; 32(43):15227-42. PMC: 3506191. DOI: 10.1523/JNEUROSCI.3545-12.2012. View